These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37307155)

  • 1. Angiopep-2 Grafted PAMAM Dendrimers for the Targeted Delivery of Temozolomide:
    Sahoo RK; Kumar H; Jain V; Sinha S; Ajazuddin ; Gupta U
    ACS Biomater Sci Eng; 2023 Jul; 9(7):4288-4301. PubMed ID: 37307155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan Engineered PAMAM Dendrimers as Nanoconstructs for the Enhanced Anti-Cancer Potential and Improved In vivo Brain Pharmacokinetics of Temozolomide.
    Sharma AK; Gupta L; Sahu H; Qayum A; Singh SK; Nakhate KT; Ajazuddin ; Gupta U
    Pharm Res; 2018 Jan; 35(1):9. PubMed ID: 29294212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting.
    Wang L; Tang S; Yu Y; Lv Y; Wang A; Yan X; Li N; Sha C; Sun K; Li Y
    Mol Pharm; 2021 Mar; 18(3):915-927. PubMed ID: 33417456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendrimer encapsulated and conjugated delivery of berberine: A novel approach mitigating toxicity and improving in vivo pharmacokinetics.
    Gupta L; Sharma AK; Gothwal A; Khan MS; Khinchi MP; Qayum A; Singh SK; Gupta U
    Int J Pharm; 2017 Aug; 528(1-2):88-99. PubMed ID: 28533175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring temozolomide encapsulated PEGylated liposomes and lyotropic liquid crystals for effective treatment of glioblastoma: in-vitro, cell line, and pharmacokinetic studies.
    Waghule T; Laxmi Swetha K; Roy A; Narayan Saha R; Singhvi G
    Eur J Pharm Biopharm; 2023 May; 186():18-29. PubMed ID: 36924995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEGylated Dendrimer Mediated Delivery of Bortezomib: Drug Conjugation versus Encapsulation.
    Sahoo RK; Gothwal A; Rani S; Nakhate KT; Ajazuddin ; Gupta U
    Int J Pharm; 2020 Jun; 584():119389. PubMed ID: 32380027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel RGDyC/PEG co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting delivery system.
    Lu Y; Han S; Zheng H; Ma R; Ping Y; Zou J; Tang H; Zhang Y; Xu X; Li F
    Int J Nanomedicine; 2018; 13():5937-5952. PubMed ID: 30323584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temozolomide-fatty acid conjugates for glioblastoma multiforme: In vitro and in vivo evaluation.
    Jatyan R; Sahel DK; Singh P; Sakhuja R; Mittal A; Chitkara D
    J Control Release; 2023 Jul; 359():161-174. PubMed ID: 37182806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation of temozolomide-loaded nanoparticles and their targeting potential to melanoma cells.
    Jiang G; Li R; Tang J; Ma Y; Hou X; Yang C; Guo W; Xin Y; Liu Y
    Oncol Rep; 2017 Feb; 37(2):995-1001. PubMed ID: 28035395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-targeting immunoliposomes using angiopep-2 and CD133 antibody for glioblastoma stem cells.
    Kim JS; Shin DH; Kim JS
    J Control Release; 2018 Jan; 269():245-257. PubMed ID: 29162480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.
    Gu Z; Wang M; Fang Q; Zheng H; Wu F; Lin D; Xu Y; Jin Y
    Drug Dev Ind Pharm; 2015 May; 41(5):812-8. PubMed ID: 24745851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted delivery of temozolomide by nanocarriers based on folic acid-hollow TiO
    Uribe-Robles M; Ortiz-Islas E; Rodriguez-Perez E; Valverde FF; Lim T; Martinez-Morales AA
    Biomater Adv; 2023 Aug; 151():213442. PubMed ID: 37207587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of Temozolomide and N3-Propargyl Analog to Brain Tumors Using an Apoferritin Nanocage.
    Bouzinab K; Summers HS; Stevens MFG; Moody CJ; Thomas NR; Gershkovich P; Weston N; Ashford MB; Bradshaw TD; Turyanska L
    ACS Appl Mater Interfaces; 2020 Mar; 12(11):12609-12617. PubMed ID: 32073826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy.
    Song S; Mao G; Du J; Zhu X
    Drug Deliv; 2016 May; 23(4):1404-8. PubMed ID: 26203687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic Newcastle Disease Virus Co-Delivered with Modified PLGA Nanoparticles Encapsulating Temozolomide against Glioblastoma Cells: Developing an Effective Treatment Strategy.
    Kadhim ZA; Sulaiman GM; Al-Shammari AM; Khan RA; Al Rugaie O; Mohammed HA
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of a Targeted Treatment for Brain Tumors Using a Multi-Drug Loaded, Relapse-Resistant Polymeric Theranostic.
    Chu W; Houston ZH; Fletcher NL; Huda P; Ahamed M; Lim TX; Day BW; Pinkham M; Thurecht KJ
    Biomacromolecules; 2023 Jun; 24(6):2674-2690. PubMed ID: 37143361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Temozolomide-Conjugated Gold Nanoparticle Photothermal Therapy of Drug-Resistant Glioblastoma and Its Mechanism Study.
    Yu Y; Wang A; Wang S; Sun Y; Chu L; Zhou L; Yang X; Liu X; Sha C; Sun K; Xu L
    Mol Pharm; 2022 Apr; 19(4):1219-1229. PubMed ID: 35262365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiopep-2-Functionalized Lipid Cubosomes for Blood-Brain Barrier Crossing and Glioblastoma Treatment.
    Cai X; Refaat A; Gan PY; Fan B; Yu H; Thang SH; Drummond CJ; Voelcker NH; Tran N; Zhai J
    ACS Appl Mater Interfaces; 2024 Mar; 16(10):12161-12174. PubMed ID: 38416873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celecoxib substituted biotinylated poly(amidoamine) G3 dendrimer as potential treatment for temozolomide resistant glioma therapy and anti-nematode agent.
    Uram Ł; Markowicz J; Misiorek M; Filipowicz-Rachwał A; Wołowiec S; Wałajtys-Rode E
    Eur J Pharm Sci; 2020 Sep; 152():105439. PubMed ID: 32615261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grafting, characterization and enhancement of therapeutic activity of berberine loaded PEGylated PAMAM dendrimer for cancerous cell.
    Yadav D; Semwal BC; Dewangan HK
    J Biomater Sci Polym Ed; 2023 Jun; 34(8):1053-1066. PubMed ID: 36469754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.